導(dǎo)讀:醫(yī)療設(shè)備用膠黏劑和密封劑技術(shù)的發(fā)展,導(dǎo)致了這方面粘合劑的需求急劇增長(zhǎng)。作為減輕患者疼痛且更為安全的選擇,目前,這一利用先進(jìn)的密封劑和膠黏劑的新技術(shù),正迅速的取代傳統(tǒng)的縫合線和手術(shù)鉗。
Advances in adhesive and sealant technology for medical applications are leading to a sharp increase in demand. New methods that make use of advanced sealants and adhesives are rapidly replacing traditional sutures, wires and staples as a less painful and safer option.
Although there are synthetic and semi-synthetic medical adhesives and sealants, biological or natural sealants and adhesives enjoy the largest market share. Fibrin-based products dominate, butgelatin and collagen based sealants and adhesives are rapidly gaining ground.
These sealants and adhesives are most widely used in neurological surgery, but are also used in a range of other surgical processes including cardiovascular surgery, urological surgery and ophthalmic surgery. North America is currently the primary market for surgical adhesives and sealants, but demand in the Asia-Pacific region is the fastest-growing.
A large number of companies are active within this market including Johnson & Johnson, Baxter International Inc., Medtronic PLC,Cohera Medical Inc., Sanofi Group, B. Braun Melsungen AG, C.R. Bard Inc., Vivostat A/S., Ocular Therapeutix Inc., and Cryolife Inc.
本站所有信息與內(nèi)容,版權(quán)歸原作者所有。網(wǎng)站中部分新聞、文章來源于網(wǎng)絡(luò)或會(huì)員供稿,如讀者對(duì)作品版權(quán)有疑議,請(qǐng)及時(shí)與我們聯(lián)系,電話:025-85303363 QQ:2402955403。文章僅代表作者本人的觀點(diǎn),與本網(wǎng)站立場(chǎng)無關(guān)。轉(zhuǎn)載本站的內(nèi)容,請(qǐng)務(wù)必注明"來源:林中祥膠粘劑技術(shù)信息網(wǎng)(www.423344.com)".
更多
©2015 南京愛德福信息科技有限公司 蘇ICP備10201337 | 技術(shù)支持:南京聯(lián)眾網(wǎng)絡(luò)科技有限公司